Fingolimod initiation and cardiac safety trial
Phase of Trial: Phase III
Latest Information Update: 01 May 2015
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Acronyms FIRST
- Sponsors Novartis
- 19 Apr 2012 Results were reported in a Novartis media release.
- 19 Apr 2012 Status changed to completed.
- 21 Oct 2011 New trial record